Medical Electrical Stimulation Market By Type (Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices, Gastric Electric Stimulation (GES) Devices, Transcutaneous electrical nerve stimulation (TENS) Devices, Neuromuscular Electrical Stimulation (NMES/EMS) Devices, and Others), By Application (Pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management, Incontinence Management, and Others), Industry Trends, Estimation & Forecast, 2023-2030

Market Overview

Electrical stimulation device transmits electrical current to muscles to make them contract.Electrical stimulation helps to treat muscular contraction as a result of wounds or neurological ailments. There are various type of electrical stimulation device including Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices, Gastric Electric Stimulation (GES) Devices, Transcutaneous electrical nerve stimulation (TENS) Devices, Neuromuscular Electrical Stimulation (NMES/EMS) Devices andmore.

Medical Electrical Stimulation market is estimated to reach $9.4 billion by 2030; growing at a CAGR of 6.3% till 2030

Market Dynamics

Rising Incidence and Awareness of Neurodegenerative Disorders is boosting the global Medical Electrical Stimulation market. For instance, according to the World Health Organization (WHO), neurodegenerative diseases affect approximately 30 million individuals worldwide. According to the Alzheimer’s Association, in 2019, around 50 million people had Alzheimer’s or related dementia globally. In 2019, more than 5 million Americans of all ages had Alzheimer’s, and the number will rise by nearly 14 million by 2050. According to Harvard NeuroDiscovery Center, in 2019, around 1 million Americans have Parkinson’s, 400,000 from multiple sclerosis, 30,000 from amyotrophic lateral sclerosis, and 30,000 from Huntington’s disease. The regulatory bodies are conducting research programs for the awareness of Neurodegenerative Disorders. For instance, Health Europa has conducted a Joint Programme on Neurodegenerative Disease Research (JPND) across 30 countries. The JPND aimed to discover better cures, treatments and diagnostic tools for neurodegenerative diseases. The companies are directing conferences to spread awareness among people about Neurodegenerative Disorders is improving market growth. Moreover, Increasing regulatory approvals for Medical Electrical Stimulation are key driving factors of the market. However, Risks associated with neurostimulation devices might hamper market growth. According to the U.S. Food and Drug Administration (FDA), Spinal Cord Stimulator is the third-highest number of medical device injury reports, with more than 80,000 incidents flagged until 2018. The risk associated due to neurostimulation devices includes Device malfunctions, Shocks or burns, Infection, Spinal cord nerve damage, muscle weakness, and Paraplegia. Further, Increasing funding for neurostimulation devices would provide lucrative opportunities for the market in the coming years.

Market Segmentation

The global Medical Electrical Stimulation market is mainly classified based on Type, Application. Type is further segmented into Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices, Gastric Electric Stimulation (GES) Devices, Transcutaneous electrical nerve stimulation (TENS) Devices, Neuromuscular Electrical Stimulation (NMES/EMS) Devices, Others.By Application, the market is divided into Pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management, Incontinence Management, Others.

Spinal Cord Stimulation (SCS) Devices is dominating the global Medical Electrical Stimulation market by type. Spinal cord stimulator (SCS) device is surgically placed under the skin and helps to send a mild electric current to the spinal cord at the area of pain.The increase in development of new Spinal Cord Stimulation (SCS) system and competitive advancement to increase product portfolio and revenue would improve the market growth. For instance, Boston has introduced the Spectra WaveWriter Spinal Cord Stimulator (SCS) System in Europe. The Spectra WaveWriter SCS System is the first system for the treatment of chronic pain to combine paresthesia-based and sub-perception therapy simultaneously. Moreover, Medtronic has acquired Stimgenics. Stimgenicsdeveloped novel spinal cord stimulation (SCS) waveform and differential target multiplexed (DTM). Medtronic has addedStimgenics’ differential target multiplexed spinal cord stimulation waveform to its Intellis spinal cord stimulation device for the treatment of chronic pain.

Regional Analysis

Based on geography, the global Medical Electrical Stimulation market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

North America is dominating the global Medical Electrical Stimulation market in 2019, due to the increasing regulatory approval for the products. For instance, the U.S. Food and Drug Administration (FDA) has approved Abbott’s Proclaim XR recharge-free neurostimulation system for the treatment of chronic pain. Moreover, InControl Medical has received the U.S. Food and Drug Administration (FDA) approval for Attain. It is the first over the counter (OTC) non-implantable muscle stimulator designed for at-home use to treat women suffering from stress, urge, mixed urinary incontinence and bowel incontinence.

North America Medical Electrical Stimulation market is estimated to grow at a CAGR of 6.4%.

Competitive landscape

Key players operating in the Medical Electrical Stimulation industry include Medtronic, Boston Scientific Corporation, Abbott, Livanova, Nevro Corporation, Neurosigma, Inc., Neuropace, Inc., Biocontrol Medical, Synapse Biomedical, Neuronetics.

Formation of strategic collaborations and commercialization of approved products are the few business strategies adopted by the key companies, with a focus on maintaining a competitive advantage over others. The companies are focused on introducing new electrical stimulation device. For instance, on January22, 2020, Soin Neuroscience, a biotechnology company, has developed a new spinal cord stimulation device to treat chronic pain. Moreover, on January 09, 2020, Medtronic plc has received CE Mark approval for the Percept PC Neurostimulator Deep Brain Stimulation (DBS) System with BrainSense Technology. Percept PC neurostimulator has approved for the treatment of Parkinson’s disease (PD), primary dystonia as well as epilepsy, essential tremor, and obsessive-compulsive disorder (OCD).

Medical Electrical Stimulation Market Key Segments

By Type
• Spinal Cord Stimulation (SCS) Devices
• Deep Brain Stimulation (DBS) Devices
• Vagus Nerve Stimulation (VNS) Devices
• Sacral Nerve Stimulation (SNS) Devices
• Gastric Electric Stimulation (GES) Devices
• Transcutaneous electrical nerve stimulation (TENS) Devices
• Neuromuscular Electrical Stimulation (NMES/EMS) Devices
• Others

By Application
• Pain Management
• Neurological and Movement Disorder Management
• Musculoskeletal Disorder Management
• Metabolism & GIT Management
• Incontinence Management
• Others

By Geography

• North America
o The U.S.
o Canada
o Mexico

• Europe
o U.K
o Germany
o France
o Italy
o Rest of Europe

• Asia Pacific
o India
o China
o Japan
o South Korea
o Rest of Asia Pacific

• South America
o Brazil
o Argentina
o Rest of South America

• Middle East & Africa
o GCC Countries
o Egypt
o South Africa
o Rest of Middle East & Africa

Key Global Medical Electrical Stimulation Industry Players

• Medtronic
• Boston Scientific Corporation
• Abbott
• Livanova
• Nevro Corporation
• Neurosigma, Inc.
• Neuropace, Inc.
• Biocontrol Medical
• Synapse Biomedical
• Neuronetics

Table of Content

1. Market Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. Market Scope

2. Research Methodology
2.1. Primary Research
2.2. Research Methodology
2.3. Assumptions & Exclusions
2.4. Secondary data sources

3. Medical Electrical Stimulation Market Overview
3.1. Report Segmentation & Scope
3.2. Key Market Trend
3.3. Drivers
3.3.1. Rising Incidence and Awareness of Neurodegenerative Disorders
3.3.2. Increasing regulatory approvals for Medical Electrical Stimulation
3.4. Restraints
3.4.1. Risks associated with neurostimulation devices
3.5. Opportunity
3.5.1. Increasing funding for neurostimulation devices
3.6. Porter’s Five Forces Analysis
3.6.1. Porter’s Five Forces Analysis
3.7. Market Share Analysis

4. Type Overview
4.1. Introduction
4.1.1. Market Size & Forecast
4.2. Spinal Cord Stimulation (SCS) Devices
4.2.1. Market Size & Forecast
4.3. Deep Brain Stimulation (DBS) Devices
4.3.1. Market Size & Forecast
4.4. Vagus Nerve Stimulation (VNS) Devices
4.4.1. Market Size & Forecast
4.5. Sacral Nerve Stimulation (SNS) Devices
4.5.1. Market Size & Forecast
4.6. Gastric Electric Stimulation (GES) Devices
4.6.1. Market Size & Forecast
4.7. Transcutaneous electrical nerve stimulation (TENS) Devices
4.7.1. Market Size & Forecast
4.8. Neuromuscular Electrical Stimulation (NMES/EMS) Devices
4.8.1. Market Size & Forecast
4.9. Others
4.9.1. Market Size & Forecast

5. Application Overview
5.1. Introduction
5.1.1. Market Size & Forecast
5.2. Pain Management
5.2.1. Market Size & Forecast
5.3. Neurological and Movement Disorder Management
5.3.1. Market Size & Forecast
5.4. Musculoskeletal Disorder Management
5.4.1. Market Size & Forecast
5.5. Metabolism & GIT Management
5.5.1. Market Size & Forecast
5.6. Incontinence Management
5.6.1. Market Size & Forecast
5.7. Others
5.7.1. Market Size & Forecast

6. Medical Electrical Stimulation Market Regional Overview
6.1. Introduction
6.1.1. Market Size & Forecast
6.2. North America Medical Electrical Stimulation Market
6.2.1. North America Market Size & Forecast, By Country
6.2.2. North America Market Size & Forecast, By Type
6.2.3. North America Market Size & Forecast, By Application
6.2.4. The U.S.
6.2.4.1. Market Size and Forecast
6.2.5. Canada
6.2.5.1. Market Size and Forecast
6.2.6. Mexico
6.2.6.1. Market Size and Forecast
6.3. Europe Medical Electrical Stimulation Market
6.3.1. Europe Market Size & Forecast, By Country
6.3.2. Europe Market Size & Forecast, By Type
6.3.3. Europe Market Size & Forecast, By Application
6.3.4. Germany
6.3.4.1. Market Size and Forecast
6.3.5. France
6.3.5.1. Market Size and Forecast
6.3.6. UK
6.3.6.1. Market Size and Forecast
6.3.7. Italy
6.3.7.1. Market Size and Forecast
6.3.8. Spain
6.3.8.1. Market Size and Forecast
6.3.9. Rest of Europe
6.3.9.1. Market Size and Forecast
6.4. Asia-Pacific Medical Electrical Stimulation Market
6.4.1. Asia-Pacific Market Size & Forecast, By Country
6.4.2. Asia-Pacific Market Size & Forecast, By Type
6.4.3. Asia-Pacific Market Size & Forecast, By Application
6.4.4. Japan
6.4.4.1. Market Size and Forecast
6.4.5. China
6.4.5.1. Market Size and Forecast
6.4.6. Australia
6.4.6.1. Market Size and Forecast
6.4.7. India
6.4.7.1. Market Size and Forecast
6.4.8. South Korea
6.4.8.1. Market Size and Forecast
6.4.9. Rest of Asia-Pacific
6.4.9.1. Market Size and Forecast
6.5. South America Medical Electrical Stimulation Market
6.5.1. South America Market Size & Forecast, By Country
6.5.2. South America Market Size & Forecast, By Type
6.5.3. South America Market Size & Forecast, By Application
6.5.4. Brazil
6.5.4.1. Market Size and Forecast
6.5.5. Argentina
6.5.5.1. Market Size and Forecast
6.5.6. Rest of South America
6.5.6.1. Market Size and Forecast
6.6. Middle East & Africa Medical Electrical Stimulation Market
6.6.1. Middle East & Africa Market Size & Forecast, By Country
6.6.2. Middle East & Africa Market Size & Forecast, By Type
6.6.3. Middle East & Africa Market Size & Forecast, By Application
6.6.4. GCC Countries
6.6.4.1. Market Size and Forecast
6.6.5. Egypt
6.6.5.1. Market Size and Forecast
6.6.6. South Africa
6.6.6.1. Market Size and Forecast
6.6.7. Rest of Middle East & Africa
6.6.7.1. Market Size and Forecast

7. Company Profile
7.1. Medtronic
7.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2. Medtronic Product Category, Application, and Specification
7.1.3. Medtronic Financial Performance (2016-2018)
7.1.4. Main Business/Business Overview
7.2. Boston Scientific Corporation
7.3. Abbott
7.4. Livanova
7.5. Nevro Corporation
7.6. Neurosigma, Inc.
7.7. Neuropace, Inc.
7.8. Biocontrol Medical
7.9. Synapse Biomedical
7.10. Neuronetics